Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes

British Journal of Haematology

Volumn 154, Issue 2, 2011, Pages 281-284

  Singer, Sylvia T ^a   Vichinsky, Elliott P ^a   Sweeters, Nancy ^a   Rachmilewitz, Eliezer ^b  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Darbepoetin alfa; Erthropoeitin; Thalassaemia intermedia

Indexed keywords

CYANOCOBALAMIN; ERYTHROPOIETIN; FERRITIN; FOLIC ACID; HEMOGLOBIN; HEMOGLOBIN F; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ADULT; ALPHA THALASSEMIA; ANEMIA; BETA THALASSEMIA; BLOOD CELL COUNT; CLINICAL ARTICLE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LETTER; MALE; PHENOTYPE; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL; TREATMENT DURATION; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; ANEMIA; BETA-THALASSEMIA; ERYTHROPOIETIN; FEMALE; HEMATINICS; HUMANS; MALE; YOUNG ADULT;

EID: 79959842540     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08617.x     Document Type: Letter

References (10)

1. Bourantas, K., Economou, G. & Georgiou, J. (1997) Administration of high doses of recombinant human erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial. European Journal of Haematology, 58, 22-25.
2. Cermak, J. (2006) Erythropoietin administration may potentiate mobilization of storage iron in patients on oral iron chelation therapy. Hemoglobin, 30, 105-112.
3. Fortenko, O.M., Schaef Johns, G.J. & Kudva, G.C. (2009) Erythropoietin for hemoglobin H disease. Annals of Hematology, 88, 179-180.
4. Galanello, R., Barella, S., Turco, M.P., Giagu, N., Cao, A., Dore, F., Liberato, N.L., Guarnone, R. & Barosi, G. (1994) Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients. Blood, 83, 561-565.
5. Maccio, A., Madeddu, C., Chessa, P., Mantovani, G. & Galanello, R. (2009) Use of erythropoiesis stimulating agents for the treatment of anaemia and related fatigue in a pregnant woman with HbH disease. British Journal of Haematology, 146, 335-337.
6. Meo, A., Cassinerio, E., Castelli, R., Bignamini, D., Perego, L. & Cappellini, M.D. (2008) Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review. International Journal of Laboratory Hematology, 30, 425-431.
7. O'Donnell, A., Premawardhena, A., Arambepola, M., Allen, S.J., Peto, T.E., Fisher, C.A., Rees, D.C., Olivieri, N.F. & Weatherall, D.J. (2007) Age-related changes in adaptation to severe anemia in childhood in developing countries. Proceedings of the National Academy of Sciences of the United States of America, 104, 9440-9444.
8. Perrine, S.P. (2005) Fetal globin induction-can it cure beta thalassemia? Hematology American Society of Hematology. Education Program, 38-44.
9. Rachmilewitz, E.A., Aker, M., Perry, D. & Dover, G. (1995) Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta-thalassaemia. British Journal of Haematology, 90, 341-345.
10. Sukpanichnant, S., Opartkiattikul, N., Fucharoen, S., Tanphaichitr, V.S., Hasuike, T. & Tatsumi, N. (1997) Difference in pattern of erythropoietin response between beta-thalassemia/hemoglobin E children and adults. Southeast Asian Journal of Tropical Medicine and Public Health, 28(Suppl 3), 134-137.